Duloxetine Delayed-release Capsules USP, 20 mg, 50 Capsules (5 x 10) Unit Dose per carton, unit d...

FDA Recall #D-0055-2018 — Class II — October 6, 2017

Recall #D-0055-2018 Date: October 6, 2017 Classification: Class II Status: Terminated

Product Description

Duloxetine Delayed-release Capsules USP, 20 mg, 50 Capsules (5 x 10) Unit Dose per carton, unit dose blister UPC 5026828311), Rx only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, NDC 50268-283-15.

Reason for Recall

Failed Impurities/Degradation Specifications: slightly elevated levels of phthalic acid.

Recalling Firm

AVKARE Inc. — Pulaski, TN

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

274 cartons

Distribution

Nationwide in the USA

Code Information

Lot: 18103 Exp. 11/18

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated

What Should You Do?

Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.

Back to All Drug Recalls